Latest / Stock Movers / United Health Earnings Setback; Eli Lilly Soars; TSMC Beats Forecast
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg data.
- 0:17Speaker 2: Let's take a look at some stocks on the move today.
- 0:19Speaker 2: We're joined by Lisa Stockmover's MATEO you.
- 0:23Speaker 3: Got it, and we're going to start with that. And
- 0:24Speaker 3: we're gonna start with United Health because their shares have
- 0:26Speaker 3: really been down as much as twenty percent before the bell.
- 0:29Speaker 3: So here's the basic rundown. It cut its earnings outlook
- 0:32Speaker 3: for the year, reported first quarter earnings below estimates on
- 0:36Speaker 3: but it pointed to this surprise jump in medical costs
- 0:39Speaker 3: that where they say, we're far above what it expected.
- 0:42Speaker 3: I mean, they're the largest seller of Medicare advantage health plans, right.
- 0:44Speaker 3: They also cited unanticipated changes in its optim healthcare delivery
- 0:49Speaker 3: business and that's affecting reimbursements. But the analysts are basically
- 0:52Speaker 3: what they're saying is that it's rare for the company
- 0:55Speaker 3: to cut its guidance because it typically forecasts a little
- 0:57Speaker 3: bit more conservatively and it's often raises the outlook as
- 1:01Speaker 3: of your progressive So that's kind of the difference there.
- 1:03Speaker 3: But it's affecting other ones. We see Humana, you know,
- 1:06Speaker 3: their shares were a lower. CVS Health companies like that,
- 1:09Speaker 3: their shares were also lower this morning. So it started
- 1:11Speaker 3: to affect other companies. It's like this trickle down effect.
- 1:14Speaker 3: And then shares of Hurts. They have been up as
- 1:17Speaker 3: much as about twenty percent, but yesterday, I mean fifty
- 1:20Speaker 3: six percent, up that much at the close yesterday that
- 1:23Speaker 3: was his biggest gain ever. And that's when the news
- 1:26Speaker 3: came out. CNBC said that Bill Lackman's Pershing Square Capital
- 1:29Speaker 3: had taken a nearly twenty percent stake in the company.
- 1:32Speaker 3: So if you're looking for their specifics in the filing,
- 1:35Speaker 3: it said it bought twelve point seven million shares that
- 1:38Speaker 3: were valued about's forty six point five million dollars. CNBC
- 1:41Speaker 3: later reported that position was about nineteen point eight because
- 1:45Speaker 3: it included shares and swaps. But what it does is
- 1:47Speaker 3: it makes Pershing Square the company's second largest shareholder. But
- 1:52Speaker 3: we all know how Hurtz has been changing. Remember when
- 1:54Speaker 3: they bought all those teslas, right, the problem with that,
- 1:57Speaker 3: so it's really been going down. It's fall The stock
- 1:59Speaker 3: is for gold custos, sir, you are time I walked
- 2:04Speaker 3: right up to I didn't go to the counter, go
- 2:06Speaker 3: right to the car.
- 2:07Speaker 1: We ran to the.
- 2:07Speaker 2: Hurts car a number of years ago up in Maine,
- 2:11Speaker 2: land of black flies, and the overage on top of
- 2:14Speaker 2: the bill were insulting. They built the ticket up like
- 2:17Speaker 2: I've never seen.
- 2:18Speaker 1: Yeah, I don't know's I like it? Yeah, I'm a fan.
- 2:22Speaker 1: So they do very very well with.
- 2:23Speaker 3: You did you run the tesla? I didn't do that.
- 2:26Speaker 2: You get to Harvard right off, of course?
- 2:28Speaker 1: Yeah?
- 2:28Speaker 3: Okay, next, okay, Eli, Lily, their share hasn't been down
- 2:32Speaker 3: as much as twelve percent, and it has to do
- 2:34Speaker 3: with the battleful weight loss drugs, right, we've been talking
- 2:36Speaker 3: about it. Lily getting some good news because they've been
- 2:39Speaker 3: working on this experimental GLP one pill. Everyone met the
- 2:43Speaker 3: shot talking yeah, cause everyone's like, oh, the shots, I
- 2:45Speaker 3: don't know, but the pill is what everyone's talking about.
- 2:47Speaker 3: So the new data show that it worked just as
- 2:50Speaker 3: well as novoor Nords Ozmpic shot, which is interesting. It
- 2:54Speaker 3: showed patients lost about sixteen pounds seven point nine percent
- 2:57Speaker 3: of their body weight. And what's even more is that
- 3:00Speaker 3: they hadn't even lost like that reached that plateau, So
- 3:03Speaker 3: it could show they have more to lose on top
- 3:05Speaker 3: of it. But the biggest difference was the blood sugar levels,
- 3:10Speaker 3: because that's what a lot of people are going to
- 3:12Speaker 3: do it for. The pill lowered the blood sugar levels
- 3:15Speaker 3: by an average of one point three percent. Was that big?
- 3:17Speaker 3: It was minaturing the shot for a long time now
- 3:20Speaker 3: to a certain somebody.
- 3:22Speaker 1: And easy pasy. But the side effects, you're pretty.
- 3:26Speaker 3: Noticeable, Like the whole nausea thing is yeah, I have
- 3:29Speaker 3: to someone I know who was doing the shot PI
- 3:31Speaker 3: nausea and the bathroom runs are a little sorry, are
- 3:39Speaker 3: you just putting it out there? One more TSMC rose
- 3:42Speaker 3: as much in five seven five percent, the reason why
- 3:45Speaker 3: it just forecasts sales second quarter beat estimates. It also
- 3:49Speaker 3: kept its growth outlook for twenty twenty five expectations a AI.
- 3:53Speaker 3: They say revenue doubling, so good forecast for AI.
- 3:58Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 4:02Speaker 1: us throughout the day for the latest roundup of companies
- 4:05Speaker 1: making news on Wall Street and for the latest market
- 4:08Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:12Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto. With
- 4:16Speaker 1: the Bloomberg Business app